A multivariate insight into the in vitro antitumour screen database of the National Cancer Institute: classification of compounds, similarities among cell lines and the influence of molecular targets
- PMID: 11289076
- DOI: 10.1023/a:1008171426412
A multivariate insight into the in vitro antitumour screen database of the National Cancer Institute: classification of compounds, similarities among cell lines and the influence of molecular targets
Abstract
A multivariate insight into the in vitro antitumour screen database of the NCI by means of the SIMCA package allows to propose hypotheses on the mechanism of action of novel anticancer compounds. As an example, the application of multivariate analysis to the NCI standard database provided clues to the classification of drugs whose mechanism is either unknown or controversial. Moreover, the influence of intrinsic biochemical cell line properties (molecular targets) on the sensitivity to drug treatment could be evaluated simultaneously for classes of compounds which act by the same mechanism. Interestingly, the present approach can also provide a correlation between the molecular targets and the therapeutical fingerprint of novel active compounds thus suggesting specific biochemical studies for the investigation of new mechanisms of drug action and resistance. The statistical approach reported here represents a valuable tool for handling theenormous data sets deriving from recent genome-wide investigations of gene expression in the NCI cell lines.
Similar articles
-
Shortcuts in genome-scale cancer pharmacology research from multivariate analysis of the National Cancer Institute gene expression database.Biochem Pharmacol. 2001 Sep 1;62(5):547-53. doi: 10.1016/s0006-2952(01)00711-0. Biochem Pharmacol. 2001. PMID: 11585051
-
Mining and visualizing large anticancer drug discovery databases.J Chem Inf Comput Sci. 2000 Mar-Apr;40(2):367-79. doi: 10.1021/ci990087b. J Chem Inf Comput Sci. 2000. PMID: 10761142
-
Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action.Pharmacogenomics J. 2005;5(6):381-99. doi: 10.1038/sj.tpj.6500331. Pharmacogenomics J. 2005. PMID: 16103895
-
Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics.Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S74-9. doi: 10.1007/s00280-003-0649-1. Epub 2003 Jun 18. Cancer Chemother Pharmacol. 2003. PMID: 12819939 Review.
-
Anticancer metal compounds in NCI's tumor-screening database: putative mode of action.Biochem Pharmacol. 2005 Apr 1;69(7):1009-39. doi: 10.1016/j.bcp.2005.01.001. Biochem Pharmacol. 2005. PMID: 15763539 Review.
Cited by
-
N-benzoxazol-2-yl-N'-1-(isoquinolin-3-yl-ethylidene)-hydrazine, a novel compound with antitumor activity, induces radicals and dissipation of mitochondrial membrane potential.Invest New Drugs. 2009 Jun;27(3):189-202. doi: 10.1007/s10637-008-9156-x. Epub 2008 Jul 9. Invest New Drugs. 2009. PMID: 18612590
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials